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A leucine-supplemented diet improved
protein content of skeletal muscle in
young tumor-bearing rats
Cachexia is a poorly understood syndrome
characterized by anorexia, generalized host
wasting, and a variety of metabolic alter-
ations, which can result in death (1). The
decrease in lean body mass is probably due
to a reduction in protein synthesis and/or an
increase in catabolism. Many studies have
demonstrated that the tumor acts as a nitro-
gen trap, especially for amino acids, and
competes with the host for amino acids and
glucose to satisfy its requirements (1-3).
Amino acids, especially branched-chain
amino acids (BCAA), play a regulatory role
in modulating both protein synthesis and
degradation in a wide range of tissues. Ex-
perimental evidence indicates that a major
proportion of the increase in skeletal muscle
protein synthesis observed in vivo following
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Abstract
Cancer cachexia induces host protein wastage but the mechanisms are
poorly understood. Branched-chain amino acids play a regulatory role
in the modulation of both protein synthesis and degradation in host
tissues. Leucine, an important amino acid in skeletal muscle, is higher
oxidized in tumor-bearing animals. A leucine-supplemented diet was
used to analyze the effects of Walker 256 tumor growth on body
composition in young weanling Wistar rats divided into two main
dietary groups: normal diet (N, 18% protein) and leucine-rich diet (L,
15% protein plus 3% leucine), which were further subdivided into
control (N or L) or tumor-bearing (W or LW) subgroups. After 12
days, the animals were sacrificed and their carcass analyzed. The
tumor-bearing groups showed a decrease in body weight and fat
content. Lean carcass mass was lower in the W and LW groups (W =
19.9 ± 0.6, LW = 23.1 ± 1.0 g vs N = 29.4 ± 1.3, L = 28.1 ± 1.9 g, P <
0.05). Tumor weight was similar in both tumor-bearing groups fed
either diet. Western blot analysis showed that myosin protein content
in gastrocnemius muscle was reduced in tumor-bearing animals (W =
0.234 ± 0.033 vs LW = 0.598 ± 0.036, N = 0.623 ± 0.062, L = 0.697
± 0.065 arbitrary intensity, P < 0.05). Despite accelerated tumor
growth, LW animals exhibited a smaller reduction in lean carcass
mass and muscle myosin maintenance, suggesting that excess leucine
in the diet could counteract, at least in part, the high host protein
wasting in weanling tumor-bearing rats.
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refeeding after a brief starvation is inde-
pendent of changes in anabolic hormones
(insulin) but is attributable to amino acids
themselves (4,5). Louard et al. (6) showed
that different proportions of dietary BCAA
had important beneficial effects on the meta-
bolic changes associated with muscle wast-
ing.
If the progression of muscle wasting seen
in malignant neoplastic disease could be
prevented, it would be of clinical importance
in terms of improving the prognosis and the
quality of life of the patients. The main
objective of the present study was to investi-
gate the effects of Walker 256 carcinosar-
coma growth on the body composition of
young rats, which were fed normal (AIN-
G93) and high leucine level diets (3% leu-
cine added to AIN-G93).
Weanling male Wistar rats (25 days old,
N = 36, from the animal facilities of
UNICAMP, CEMIB) were housed in meta-
bolic cages and kept under normal condi-
tions (22 ± 2ºC, and 12/12-h light/dark cycle)
with free access to water and food over a 12-
day period. The rats were divided into four
groups according to diet and tumor implan-
tation: control (N) and tumor-bearing (W),
which were fed an 18% protein diet, and two
other groups fed a high leucine diet: non-
tumor-bearing (L) and tumor-bearing (LW).
The semipurified control diet was AIN-G93
(7) and the high leucine diet contained 15%
protein supplemented with 3% leucine. Each
diet contained equivalent amounts of carbo-
hydrate, fat and fiber. The tumor-bearing
group was inoculated sc into the right flank
with 0.2 ml (2.5 x 105) of viable (Trypan blue
exclusion) Walker 256 carcinosarcoma cells.
The non-tumor-bearing rats were injected sc
with 0.2 ml 0.9% (w/v) NaCl solution with-
out anesthesia. General UKCCR guidelines
(1988, United Kingdom Coordinating Com-
mittee on Cancer Research) for animal wel-
fare were followed (Ethics Committee for
Animal Research CEE and COBEA, Brazil
numbered 0386-1).
Food intake, body weight, and tumor
weight (calculated from three orthogonal lin-
ear measurements using the weight dimen-
sion curve; 8) were measured every two
days. After 12 days the animals were killed
with a Nembutal overdose followed by cer-
vical dislocation. Gastrocnemius muscle
samples were weighed and homogenized in
a buffer containing 20 mM Tris HCl, pH 7.5,
2 mM ATP, 5 mM MgCl2 and 1 mM dithio-
threitol (1:4 dilution). The whole muscle
homogenate was then centrifuged for 10 min
at 9000 g, 4ºC, and the resulting supernatant
was used to determine the total protein con-
tent. Samples of muscle protein (5 µg) were
resolved on a 12% sodium dodecyl sulfate
polyacrylamide gel, transferred to a 0.45-µm
nitrocellulose membrane (Hybond-C, Amer-
sham Pharmacia Biotech, Little Chalfont,
Buckinghamshire, UK) and blocked with
5% Marvel in phosphate-buffered saline con-
taining 0.1% Tween, pH 7.5, to quantify
myosin heavy chain using a specific myosin
heavy chain primary antibody, 1:250 dilu-
tion (Novocastra, Newcastle, UK).
Nitrocellulose membranes were devel-
oped using ECL chemiluminescence (Amer-
sham) and blots quantified using a densitom-
eter. A parallel gel was silver stained to
ensure equal loading. The densitometric re-
sults were analyzed using Gel Pro Analyzer
software (Media Cybernetics, Silver Spring,
MD, USA). Body water content was calcu-
lated from the total body mass minus tumor
mass and gastrointestinal tract (stomach to
large intestine) of each rat carcass by drying
and weighing until a constant weight was
achieved. Carcasses were then cut into pieces
for soxhlet extraction of body fat. The lean
carcass mass was calculated by subtracting
dry carcass without fat from dry carcass
including fat. The determination of chemical
whole body composition followed the meth-
odology of Ventrucci et al. (9). Results are
reported as mean ± SEM and were analyzed
with the Graph Pad Prism program, v3.00 for
Windows 98. Differences were considered
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significant at P < 0.05.
Data were analyzed statistically by two-
way ANOVA, testing the effects of diet and
tumor on body chemical composition and
muscle myosin content. Comparisons within
control and tumor-bearing groups were per-
formed using one-way ANOVA followed by
post hoc Bonferroni’s multiple comparison
test (10).
The effects of a high leucine diet on
tumor growth and body composition were
examined. As shown in Table 1, the initial
food intake was similar among the four ex-
perimental groups (P > 0.05), although at the
end of the experiment both tumor-bearing
groups (W and LW) demonstrated a reduc-
tion in food intake when compared to non-
tumor-bearing rats (W vs N, P < 0.01; LW vs
L, P < 0.001; Table 1). The final body weight
values were lower in both tumor-bearing
groups (W vs N and LW vs L, P < 0.001). The
final body weight was reduced by 36.4% in
group W, differing significantly from the
control group (P < 0.001), although this dif-
ference was lower than the LW body weight
value (22.5%, LW vs L, P < 0.01). The
tumor-bearing groups showed similar final
body weight (LW = 117.4 ± 2.6 vs W = 96.8
± 5.1 g, P > 0.05) and tumor weight (W =
7.84 ± 1.04 and LW = 7.38 ± 0.62 g). The
body water content was increased in tumor-
bearing rats (P < 0.001 for group W and P <
0.05 for group LW). The total percentage of
fat was reduced in W (P < 0.01) and in LW
rats (P < 0.001) compared to the respective
control groups (Table 1). Lean body mass
was decreased in the W group (W vs N and L,
P < 0.01, Table 1), but this decrease was less
prominent in the LW group (LW vs N, P <
0.05; there was no difference between LW
and L, P > 0.05) in relation to the L group.
The LW group also showed a higher lean
carcass mass in comparison to the W group
(LW vs W, P < 0.05).
This parameter was especially affected
by tumor growth when analyzed by two-way
ANOVA, which showed a P value equal to
0.0047. The weight of the gastrocnemius
muscle (Table 1) was decreased in the W
tumor-bearing group (W = 0.152 ± 0.016 g,
P < 0.05 for W vs N), but the LW group
showed only a slight reduction in muscle
weight (LW = 0.248 ± 0.033 g). A significant
difference was observed when compared to
Table 1. Effects of leucine-supplemented diets on the characteristics of tumor-bearing groups.
N L W LW
Food intake on the 1st day (g) 7.89 ± 0.99a 7.98 ± 0.77a 8.63 ± 0.45a 10.36 ± 0.60a
Food intake on the 12th day (g) 15.33 ± 0.84a 15.86 ± 0.78a 10.33 ± 0.58b 9.18 ± 0.98b
Body weight on the 1st day (g) 67.7 ± 2.4a 69.2 ± 2.5a 64.7 ± 2.4a 67.0 ± 1.6a
Body weight on the 12th day (g) 152.3 ± 3.9a 151.5 ± 5.2a 96.8 ± 5.1b 117.4 ± 2.6b
Body weight gain (%) 205.5 ± 6.2a 197.9 ± 6.4a 158.1 ± 4.3b 168.0 ± 4.3b
Tumor weight (g) - - 7.84 ± 1.04a 7.38 ± 0.62a
Tumor weight/body weight ratio (%) - - 8.29 ± 1.01a 6.90 ± 0.58a
Body water (%) 64.1 ± 0.5a 64.4 ± 0.5a 70.4 ± 0.9b 68.4 ± 1.3b
Body fat (%) 10.7 ± 0.4a 13.7 ± 0.6b 6.2 ± 0.4c 7.9 ± 0.9c
Lean carcass mass (g) 29.4 ± 1.3a 28.1 ± 1.9a 19.9 ± 0.6b 23.1 ± 1.0a,b
Total protein carcass (mg/g) 47.94 ± 1.51a 46.71 ± 3.05a,b 42.72 ± 1.14b 43.47 ± 1.05b
Gastrocnemius muscle weight (g) 0.289 ± 0.025a,b 0.347 ± 0.025b 0.152 ± 0.016c 0.248 ± 0.033a
Gastrocnemius muscle total protein (µg/µl) 4.89 ± 0.34a 5.03 ± 0.26a 5.49 ± 0.31a 5.82 ± 0.20a
Groups: control (N); control fed a leucine-supplemented diet (L); bearing a Walker 256 carcinosarcoma (W); tumor-bearing rats receiving a leucine-
supplemented diet (LW). Data are reported as means ± SEM for 8 animals in the N and L groups and 10 animals in the W and LW groups.
Significant differences are shown in each row by different superscript letters (P < 0.05, one-way ANOVA followed by Bonferroni's test).
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the L and W groups (P < 0.05).
After equal protein loading (5 µg per
well), Western blot analysis showed a de-
crease in myosin content in the W tumor-
bearing group (P < 0.001) (Figure 1) but
there was also a small reduction in myosin
content in the LW group. However, myosin
content was significantly higher in the LW
group (0.598 ± 0.036) compared to the W
group (0.234 ± 0.033, P < 0.001). Two-way
ANOVA showed that the effects of diet and
tumor were extremely significant, with P
values of <0.0001 and 0.0008, respectively.
The weight loss observed in patients and
animals with solid tumors is primarily the
result of a loss of both muscle mass and body
fat (1,11). Although weight loss is com-
monly associated with a decrease in food
intake, anorexia does not appear to be re-
sponsible for the cachectic process. Deple-
tion of host fat stores is a common character-
istic of Walker 256 tumor-bearing rats, which
was also observed in the present study and
has been observed in other experimental
tumor-bearing models involving severe
weight loss (9,12). In an extensive review,
Tisdale (1) reported that the loss of body fat
was related, in part, to an increase in glycerol
and fatty-acid turnover, leading to increased
lipolysis and to a circulatory lipid-mobiliz-
ing factor found in both animal and human
cachectic hosts. Body fat was especially re-
duced in both tumor-bearing groups.
From our results, it was evident that body
water content was higher in tumor-bearing
rats. Other studies have also demonstrated a
similar alteration in body water content in
pregnant tumor-bearing rats (9) and in tu-
mor-bearing male rats (12). Besides the pro-
found decrease in body fat, Walker 256 car-
cinosarcoma-bearing rats showed a signifi-
cant decrease of about 15% in lean tissue
mass in comparison to control groups (9,12).
In contrast, studies on interleukin-6-secret-
ing tumor-bearing mice demonstrated a sig-
nificant loss in fat tissue without loss of lean
body mass or water content (13). Lean body
mass and visceral protein depletion is a char-
acteristic of patients with cancer cachexia
and the degree of depletion may be associ-
ated with reduced survival. According to
Cohn and colleagues (11), the non-muscle
tissue including the visceral fraction did not
change in cancer patients, and appeared to
increase in size when compared to the nor-
mal population. Although the carcass weight
loss occurred in both the W and LW groups,
it was observed that the leucine-supplemented
diet could prevent, at least in part, the car-
cass weight loss and lean carcass mass de-
crease in the LW group (Table 1). In addi-
tion, Ventrucci et al. (9) reported a signifi-
cant increase in lean body mass in pregnant
tumor-bearing animals fed a leucine-supple-
mented diet compared to the other pregnant
tumor-bearing groups. In a previous publica-
tion (14), tumor growth promoted some al-
terations in pregnant rats that could be at-
tenuated by feeding a leucine-supplemented
diet. In addition, the intestinal absorption
changes demonstrated in the leucine-supple-
mented groups could prevent hypoglycemia
and induced high leucine and methionine
absorption mainly in pregnant rats, which
Figure 1. A, Analysis of myosin
heavy chain content in gastroc-
nemius muscle of control (N),
Walker 256 carcinosarcoma-
bearing rats (W), control rats fed
a leucine-supplemented diet (L),
and tumor-bearing rats receiving
a leucine-supplemented diet
(LW). The blot is representative
of 8 muscle samples from each
group. Homogenized fractions
from whole gastrocnemius
muscle protein (5 µg) were
probed with a monoclonal anti-
body against myosin heavy chain
as described in Methods. B, Den-
sitometric analysis of myosin
heavy chain content in gastroc-
nemius muscle from four sepa-
rate blots (means ± SEM for 8
animals in each group). *P <
0.001 for the N group compared
to the W group; **P < 0.001 for
the W group compared to the
LW group (two-way ANOVA).
A
220 kDa



































Braz J Med Biol Res 36(11) 2003
Leucine-supplemented diet for tumor-bearing rats
may increase the availability of amino acids
for cells, possibly for host utilization (14).
Many studies have demonstrated that
there is a significant increase in proteolysis
in cancer patients, twice as large as that
observed in malnourished patients (1). This
wasting of lean body mass could reveal an
incapacity to conserve body protein. The
present study showed that the decrease in
lean carcass mass was associated with skel-
etal muscle myosin protein loss in tumor-
bearing groups. Indeed, these results show
that the higher the carcass wasting, the greater
the degree of loss in myosin protein (Figure
1). Studies on cancer patients have demon-
strated that skeletal muscle was the tissue
most severely affected in terms of wasting,
while visceral life-supporting tissue was, to
a considerable extent, spared (11). It has
been demonstrated that in vivo leucine oxi-
dation to CO2 is enhanced in tumor-bearing
animals (3,15) and is associated with an
increase in amino acid turnover. Argiles et
al. (16) suggested that the rate of muscle
proteolysis in catabolic states is modulated
by factors or compounds by means of a
negative feedback loop.
The effects of BCAA on host metabolism
have been analyzed in order to clarify the
mechanisms involved in altering protein turn-
over during catabolic states (such as starva-
tion, chronic infection or tumor growth).
The plasma concentration of ketone bodies
could modulate the extrahepatic oxidation
of BCAA, and a decrease in their levels
during cancer could result in increased oxi-
dation. The carbon skeletons arising from
transamination of BCAA provide a major
source of metabolic fuel for skeletal muscle
(16). Alternatively, uncontrolled BCAA oxi-
dation may be the result of hypoinsulinemia
or peripheral insulin resistance (17). The
trigger for the increased leucine oxidation
remains unknown. Interestingly, diets con-
taining different proportions of BCAA have
shown important beneficial effects on the
metabolic changes associated with muscle
protein wasting (6). The use of BCAA-en-
riched total parenteral nutrition in patients
with intra-abdominal adenocarcinomas
showed an increase in whole body protein
synthesis or improved leucine kinetics, frac-
tional albumin synthesis rates, and leucine
balance, indicating a favorable influence on
protein metabolism (18). Studies have shown
that BCAA have a clear inhibitory action on
proteolysis in skeletal muscle (19). Yoshi-
zawa et al. (5) showed that refeeding a com-
plete diet to starved rats stimulated protein
synthesis in skeletal muscle and liver, dem-
onstrating that the translation initiation in
both skeletal muscle and liver in response to
refeeding was not associated with any de-
tectable change in the activity or the phos-
phorylation state of eIF2B in the protein
synthesis process. Anthony et al. (20) stud-
ied protein synthesis in response to leucine
in rats in the post-absorptive state after ad-
ministration of leucine (1.35 g L-leucine/kg)
or saline (control) and the contribution of
insulin to this process. Knowing that BCAA
are essential nutrients and comprise up to
40% of the minimal daily requirements of
indispensable amino acids (19), this study
demonstrates that a leucine-supplemented
diet may improve body composition in tu-
mor-bearing rats, especially reducing the car-
cass weight loss, preserving lean carcass
mass and skeletal muscle myosin content
(Table 1 and Figure 1).
Further studies are underway in our labo-
ratory to determine if and how leucine sup-
plementation could counteract host carcass
wasting during cancer cachexia. The rapid
neoplastic growth induced detrimental
changes in the host due to carcass wasting.
These effects were more severe in the W
group than in the LW group. The attenuation
of host tissue wastage observed in the tumor-
bearing leucine-supplemented rats suggests
that this amino acid may act, directly and
indirectly, on mechanisms leading to stimu-
lation of synthesis and/or inhibition of the
oxidation process in host cells.
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